Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05403710

Targeting Nociceptors in Hidradenitis Suppurativa

Sponsor: University of Massachusetts, Worcester

View on ClinicalTrials.gov

Summary

This study will build on data from mice and humans implicating TRPV1 nociceptors in the pathogenesis of the type-17 chronic inflammatory skin disease Hidradenitis Suppurativa (HS). In this study, the investigators will test the hypothesis that inhibiting neuropeptide activity with botulinum toxin reduces pathogenic inflammation.

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

OBSERVATIONAL

Enrollment

20

Start Date

2022-06-07

Completion Date

2028-04-30

Last Updated

2026-09-10

Healthy Volunteers

No

Interventions

DRUG

Botulinum toxin

Administration of botulinum toxin (50 units/100cm2 injected intradermally) into lesional skin

Locations (1)

University of Massachusetts Chan Medical School

Worcester, Massachusetts, United States